CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 278 shares at $7.90 ($2,196)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Business Officer acquired 38,596 shares (grant or award)
- 4 Grant or award 10% owner acquired 10,102,435 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 6,418 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 5,216,564 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 27,917 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,102,435 shares (grant or award)
Page 6 of 8 · 151 filings